Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print September 9, 2008
DOI: 10.2337/db08-0767

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db08-0767v1
db08-0767v2
57/12/3273    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chen, Y.-G.
Right arrow Articles by Serreze, D. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-G.
Right arrow Articles by Serreze, D. V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

The Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in non-obese diabetic (NOD) mice

Yi-Guang Chen, Felix Scheuplein, Melissa A. Osborne, Shirng-Wern Tsaih, Harold D. Chapman, and David V. Serreze

1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609

Objective: While the H2g7 major histocompatibility complex (MHC) provides the primary pathogenic component, the development of T-cell-mediated autoimmune type 1 diabetes (T1D) in NOD mice also requires contributions from other susceptibility (Idd) genes. Despite sharing the H2g7 MHC, the closely NOD-related NOR strain remains T1D resistant due to contributions of protective Idd5.2, Idd9/11, and Idd13 region alleles. To aid their eventual identification, we evaluated cell types in which non-MHC Idd resistance genes in NOR mice exert disease protective effects.

Research Design and Methods: Adoptive transfer and bone marrow (BM) chimerism approaches tested the diabetogenic activity of CD4 and CD8 T-cells from NOR mice and NOD stocks congenic for NOR-derived Idd resistance loci. Tetramer staining and mimotope stimulation tested the frequency and proliferative capacity of CD4 BDC2.5-like cells. Regulatory T-cells (Tregs) were identified by Foxp3 staining and functionally assessed by in vitro suppression assays.

Results: NOR CD4 T-cells were less diabetogenic than those from NOD mice. The failure of NOR CD4 T-cells to induce T1D was not due to decreased proliferative capacity of BDC2.5 clonotypic-like cells. The frequency and function of Tregs in NOD and NOR mice were also equivalent. However, BM chimerism experiments demonstrated intrinsic factors inhibited the pathogenic activity of NOR CD4 T-cells. The NOR Idd9/11 resistance region on Chromosome 4 was found to diminish the diabetogenic activity of CD4 but not CD8 T-cells.

Conclusion: In conclusion, we demonstrated that a gene(s) within the Idd9/11 region regulates the diabetogenic activity of CD4 T-cells.


Correspondence: Email-dave.serreze{at}jax.org


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.